Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
about
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiac safety results from a ...... k node-negative breast cancer.
@ast
Cardiac safety results from a ...... k node-negative breast cancer.
@en
type
label
Cardiac safety results from a ...... k node-negative breast cancer.
@ast
Cardiac safety results from a ...... k node-negative breast cancer.
@en
prefLabel
Cardiac safety results from a ...... k node-negative breast cancer.
@ast
Cardiac safety results from a ...... k node-negative breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Cardiac safety results from a ...... k node-negative breast cancer.
@en
P2093
Barrett H Childs
Christopher T Hagenstad
David Chan
Dennis J Slamon
Frederick C Kass
Frederick P Smith
Gladys I Rodriguez
Linda D Bosserman
Sara A Hurvitz
P2860
P2888
P356
10.1186/2193-1801-3-244
P577
2014-05-12T00:00:00Z
P5875
P6179
1049988765